New hope for Tough-to-Treat ovarian cancer?

NCT ID NCT04374630

Completed Disease control Sponsor: Laekna Limited Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding a new drug called afuresertib to standard chemotherapy (paclitaxel) works better for women with platinum-resistant ovarian cancer. About 150 participants were randomly assigned to receive either the combination or chemotherapy alone. The main goal was to see if the combination could slow cancer growth for longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Abington Memorial Hospital

Willow Grove, Pennsylvania, 19090, United States
Arizona Oncology

Tucson, Arizona, 85711, United States
Arizona Oncology Associates

Phoenix, Arizona, 85016, United States
Baylor Scott & White Medical Center

Temple, Texas, 76508, United States
Beijing Obstetrics & Gynecology Hospital, Capital Medical University

Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences

Beijing, China
Chongqing University Cancer Hospital

Chongqing, China
Gynecology Oncology Associates Newport Beach

Newport Beach, California, 92663, United States
Harbin Medical University Cancer Hospital

Heilongjiang, China
Henan Cancer Hospital

Henan, China
Highlands Oncology Group

Rogers, Arkansas, 72758, United States
Holy Name Medical Center

Teaneck, New Jersey, 07666, United States
Houston Methodist Hospital

Houston, Texas, 77030, United States
Hubei Cancer Hospital

Hubei, China
Hunan Cancer Hospital

Hunan, China
Jilin Cancer Hospital

Jilin, China
Kapiolani Medical Center for Women and Children

Honolulu, Hawaii, 96826, United States
Liaoning Cancer Hospital

Liaoyang, China
MD Anderson Cancer Center at Cooper

Camden, New Jersey, 08103, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
Nebraska Methodist Hospital

Omaha, Nebraska, 68114, United States
OHCare Oncology Hematology Care (OHC), Inc. - Kenwood Office

Cincinnati, Ohio, 45242, United States
Obstetrics & Gynecology Hospital of Fudan University

Shanghai, China
Peking University Cancer Hospital

Beijing, China
Qilu Hospital of Shandong University

Shandong, China
Rocky Mountain Cancer Centers

Littleton, Colorado, 80120, United States
Southwest Women's Oncology Group

Albuquerque, New Mexico, 87106, United States
Sun Yat-sen University Cancer Center

Guangdong, China
Texas Oncology

Austin, Texas, 78731, United States
Texas Oncology

Fort Worth, Texas, 76104, United States
Texas Oncology

The Woodlands, Texas, 77380, United States
The Second Hospital of Tianjin Medical University

Tianjin, China
Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States
US Texas Oncology

San Antonio, Texas, 78240, United States
USO Texas Oncology

Longview, Texas, 75601, United States
University of Chicago

Chicago, Illinois, 60637, United States
University of Cincinnati Medical Center

Cincinnati, Ohio, 45219, United States
University of Massachusetts

Worcester, Massachusetts, 01605, United States
University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States
University of Washington/Seattle Cancer Care Alliance

Seattle, Washington, 98109, United States
Virginia Oncology Associates

Norfolk, Virginia, 23502, United States
West China Second University Hospital,Sichuan University

Sichuan, China
Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States
Women's Cancer Care

Covington, Louisiana, 70433, United States
Women's Hospital school of medicine Zhejiang University

Zhejiang, China
Zhongshan Hospital affiliated to Fudan University

Shanghai, China

Conditions

Explore the condition pages connected to this study.

PLATINUM RESISTANT OVARIAN CANCER